"Type 1 Diabetes Associated with Pegylated Interferon/Ribavirin Therapy in Chronic Hepatitis C" by Ankush Sharma, MD

Selected Works of Joseph L. Yozviak, DO, FACP

Follow Contact

Presentation

Type 1 Diabetes Associated with Pegylated Interferon/Ribavirin Therapy in Chronic Hepatitis C

Department of Medicine

Ankush Sharma, MD, Lehigh Valley Health Network
Joseph L Yozviak, DO, Lehigh Valley Health Network

Download

Publication/Presentation Date

4-1-2010

Comments

Abstract in: (2010). Journal of General Internal Medicine, 25(Suppl 3), S560-S561.

Journal available for purchase at: http://link.springer.com/journal/11606/25/3/suppl/page/1

Disciplines

Endocrinology, Diabetes, and Metabolism,
Hepatology,
Medical Sciences,
Medical Specialties and
Medicine and Health Sciences

Document Type

Poster

Citation Information

Sharma, A., & Yozviak, J. (2010, April 28-May 1). Type 1 diabetes associated with pegylated interferon/ribavirin therapy in chronic hepatitis c. Poster presented at: The 33rd Annual Meeting of the Society of General Internal Medicine, Minneapolis, MN.